AI in diagnostics offers pinpoint accuracy on a grand scale

In a significant move, Nathealth, a prominent player in the healthcare industry, has called for the inclusion of medical devices under the ERSO (Electronic Reimbursement System of India) initiative. The specific medical devices under consideration have not been disclosed.

Nathealth has also welcomed the Prime Minister's announcement on GST reforms, advocating for a standardised Goods and Services Tax (GST) rate of 5% for the healthcare sector, and input credit for the sector. However, the details of the GST reforms and their implications for the healthcare sector remain unclear.

Meanwhile, Mahajan Imaging & Labs has partnered with Fortis La Femme to provide women and child healthcare services. This collaboration is not specified in terms of its scope or duration.

In other news, Kalyan Sivasailam, the founder and CEO of both Explora and 5C Network, has not been directly linked to any recent developments. The nature of the partnership between his 5C Network and the ERSO initiative is yet to be discussed.

Zydus Therapeutics has reported positive topline results from the EPICS-III Phase 2(b)/3 Trial. However, the details of this trial, including its purpose and participants, have not been disclosed.

Finally, the International Institute of Information Technology, Hyderabad (IIITH) hosted a consultation meeting for ABDM 2.0 (Ayushman Bharat Digital Mission 2.0) in the southern region, organized by NHA (National Health Authority). The specific focus of this meeting was not detailed.

The obesity clinic program in India and the partnership between Novo Nordisk and Apollo Clinics were not referenced in the provided information.